Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients

Table 4 The best subset of variables with the strongest predictive value for the incidence of posttransplant CMV infection according to the multivariate analysis

The best subset of parameters	Multivariate analysis
The best subset of parameters	OR	95% CI	P
HGG on day 90 posttransplantation	7.6	1.7–34.1	0.008
Nonreactive QuantiFERON-CMV assay	4.2	1.1–15.6	0.033
Lymphocytopenia on day 90 posttransplantation	3.5	0.6–19.2	0.146

ISSN: 1471-2334